Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > GILD Gilead Sciences > Detailed Quotes

GILD Gilead Sciences

Watchlist
86.050
-0.310-0.36%
Close  02/07 16:00 ET
86.0500.0000.00%
Pre Mkt Price 02/08 04:00 ET
High
86.690
Open
86.600
Turnover
627.59M
Low
85.380
Pre Close
86.360
Volume
7.30M
Market Cap
107.30B
P/E(TTM)
23.64
52wk High
89.290
Shares
1.25B
P/E(Static)
23.64
52wk Low
54.817
Float Cap
107.18B
Bid/Ask %
0.00%
Historical High
95.580
Shs Float
1.25B
Volume Ratio
0.77
Historical Low
0.434
Dividend TTM
2.92
Div Yield TTM
2.92
P/B
5.06
Dividend LFY
3.39%
Div Yield LFY
3.39%
Turnover Ratio
0.59%
Amplitude
1.52%
Avg Price
85.984
Lot Size
1
Float Cap
107.18B
Bid/Ask %
0.00%
Historical High
95.580
Shs Float
1.25B
Volume Ratio
0.77
Historical Low
0.434
Dividend TTM
2.92
P/B
5.06
Dividend LFY
3.39%
Turnover Ratio
0.59%
Amplitude
1.52%
Avg Price
85.984
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
CEO: Mr. Daniel O’Day
Market: NASDAQ
Listing Date: 01/22/1992
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist